Peel Hunt reissued their buy rating on shares of Genus (LON:GNS) in a research report released on Monday, ThisIsMoney.Co.Uk reports.
A number of other research analysts have also commented on the company. Peel Hunt reissued a buy rating and set a GBX 3,200 ($41.81) price objective on shares of Genus in a report on Wednesday, September 11th. Stifel Nicolaus began coverage on Genus in a report on Wednesday, May 29th. They set a hold rating and a GBX 2,685 ($35.08) price objective on the stock. Finally, Liberum Capital reissued a buy rating on shares of Genus in a report on Friday, September 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus target price of GBX 2,819.17 ($36.84).
Shares of LON GNS opened at GBX 2,934 ($38.34) on Monday. The company has a debt-to-equity ratio of 21.92, a quick ratio of 1.19 and a current ratio of 2.01. The firm has a market cap of $1.91 billion and a price-to-earnings ratio of 246.55. The business’s 50-day simple moving average is GBX 2,653.68 and its 200-day simple moving average is GBX 2,522.17. Genus has a 52 week low of GBX 2,090 ($27.31) and a 52 week high of GBX 2,950 ($38.55).
In other Genus news, insider Lysanne Gray sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of GBX 2,858 ($37.34), for a total value of £37,096.84 ($48,473.59).
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Read More: How does quantitative easing work?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.